|
|
|
|
| LEADER |
01210nas a2200337 a 4500 |
| 001 |
.b28723843 |
| 003 |
LocatorPlus |
| 005 |
20180409105923.0 |
| 008 |
021127c20019999sp || ||| ||| 0 ||spa|c |
| 022 |
|
|
|a 1517-598X
|
| 035 |
|
|
|a 1517598X
|
| 035 |
|
|
|a 2247-19360
|
| 040 |
|
|
|a ES-BaCBU
|b cat
|c ES-BaCBU
|
| 222 |
|
0 |
|a Evidence-based medicine
|b (Edición española)
|
| 245 |
0 |
0 |
|a Evidence-based medicine
|
| 250 |
|
|
|a Ed. española
|
| 260 |
|
|
|a Madrid :
|b SANED,
|c 2001-
|
| 300 |
|
|
|a v. :
|b il.;
|c 28 cm
|
| 310 |
|
|
|a Bimestral
|
| 362 |
0 |
|
|a Vol. 1, no. 0 (nov.-dic. 2001)-
|
| 500 |
|
|
|a A la contraportada: Novartis
|
| 500 |
|
|
|a Descripció basada en: Vol. 1, no. 5 (2002, sept/oct)
|
| 580 |
|
|
|a Edició en castellà de: Evidence-based medicine (English ed.) = ISSN 1356-5524
|
| 650 |
0 |
4 |
|a Medicina basada en l'evidència
|9 4585
|
| 650 |
0 |
4 |
|a Revistes
|9 4586
|
| 710 |
2 |
|
|a Novartis Farmacéutica
|9 4587
|
| 907 |
|
|
|a .b28723843
|b 01-03-17
|c 08-05-08
|d 27-11-02
|e s
|f b
|g -
|h spa
|i sp
|j 0
|k 4
|
| 940 |
|
|
|a UAB
|
| 942 |
|
|
|2 ddc
|c CR
|
| 999 |
|
|
|c 143527
|d 143527
|
| 952 |
|
|
|0 0
|1 0
|4 0
|7 0
|9 1958616
|a SE-CBUA-USE
|b SE-CBUA-USE
|h 2001-2002(2003).
|o SE-CBUA-USE-1958616JNL-1517-598X
|p SE-CBUA-USE-1958616JNL-143527
|t 2677111
|y JNL
|
